Personalized treatment strategies, including targeted therapies and immunotherapies, have enhanced outcomes for lung cancer brain metastases.
Stereotactic radiosurgery and whole-brain radiation therapy are evolving with new systemic therapies, maintaining their importance in treatment.
Multidisciplinary approaches are crucial for optimizing treatment plans, considering genetic mutations and patient-specific factors.
Ongoing research aims to refine strategies, focusing on improved survival and quality of life for patients with brain metastases.
SHOW MORE
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.